Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
該当コードがありません。
から:
次の項目別のソート:
日付受信時刻ニュースソース見出しコード企業名
2024/09/1806 : 18Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:GSCEGoldman Sachs Group Inc (PK)
2024/09/1806 : 17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
2024/09/1806 : 17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TMCITreace Medical Concepts Inc
2024/09/1806 : 17Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:GSCEGoldman Sachs Group Inc (PK)
2024/09/1806 : 16Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:AMJBAlerian Mlp Index ETNs due January 28 2044
2024/09/1806 : 16Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:EXPEagle Materials Inc
2024/09/1806 : 16PR Newswire (Canada)2025 Tech Trends Report: Info-Tech Research Group Unveils New Insights on the Future of AI, Quantum Computing, and Cybersecurity
2024/09/1806 : 16PR Newswire (US)2025 Tech Trends Report: Info-Tech Research Group Unveils New Insights on the Future of AI, Quantum Computing, and Cybersecurity
2024/09/1806 : 15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RENBRenovaro Inc
2024/09/1806 : 15Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:BACRPBank of America Corp (PK)
2024/09/1806 : 15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
2024/09/1806 : 15Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:XXXXMax S&P 500 4x Leveraged ETN due October 30 2043
2024/09/1806 : 15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LQDALiquidia Corporation
2024/09/1806 : 15Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:GSCEGoldman Sachs Group Inc (PK)
2024/09/1806 : 15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EAElectronic Arts Inc
2024/09/1806 : 15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CHSNChanson International Holding
2024/09/1806 : 15PR Newswire (Canada)P2 Gold Announces Upsizing and Closing of Final Tranche of FinancingTSXV:PGLDP2 Gold Inc
2024/09/1806 : 15PR Newswire (US)Bioinformatics Market to Grow by USD 13.2 Billion (2024-2028) Boosted by Lower Genetic Sequencing Costs, Powered by AI - Technavio Report
2024/09/1806 : 15PR Newswire (US)Truck Rental Market to Grow by USD 40 Billion (2024-2028) as Fleet Operators Face Cost Pressure, AI Impact on Trends - Technavio Report
2024/09/1806 : 14Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:LUNRWIntuitive Machines Inc
2024/09/1806 : 14Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:GSCEGoldman Sachs Group Inc (PK)
2024/09/1806 : 14Business WireBarclays Appoints Abhishek Singhal as a Managing Director Within Technology Investment BankingLSE:BARCBarclays Plc
2024/09/1806 : 14Business WireBarclays Appoints Abhishek Singhal as a Managing Director Within Technology Investment BankingNYSE:BCSBarclays PLC
2024/09/1806 : 13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVVEWNuvve Holding Corporation
2024/09/1806 : 13Business WireCoca-Cola et Bacardi Limited annoncent leur intention de lancer le cocktail prêt-à-boire BACARDÍ & Coca-ColaNYSE:KOCoca Cola Company
2024/09/1806 : 13PR Newswire (US)Nauticus Robotics Announces Second Round of Aquanaut Mark 2 Deepwater Qualification TestingNASDAQ:KITTNauticus Robotics Inc
2024/09/1806 : 12Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNYSE:ATOAtmos Energy Corp
2024/09/1806 : 12Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:VXZiPath Series B S&P 500 VIX MidTerm Futures ETN
2024/09/1806 : 12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CCCCC4 Therapeutics Inc
2024/09/1806 : 12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CCCCC4 Therapeutics Inc